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Abstract Viral protein r (Vpr), a HIV-1 auxiliary protein
which mediates nuclear import of the viral preintegration
complex (PIC), contains two regions, N- and C-terminal, which
have been proposed to function as a nuclear localization signal
(NLS). We have synthesized peptides corresponding to both
regions (designated as VprN and VprC), conjugated them to
bovine serum albumin (BSA), and tested their ability to mediate
nuclear import in permeabilized cells. Only VprN, and not VprC,
functioned as an active NLS and promoted translocation of the
conjugate into nuclei. Nuclear import of the conjugate was found
to be energy and temperature dependent and was inhibited by
wheat germ agglutinin (WGA). However, it did not require the
addition of cytosolic factors and was not inhibited by the
prototypic SV40 large T-antigen NLS peptide. Our results show
that Vpr harbours a non-conventional negatively charged NLS
and therefore suggest that Vpr may use a distinct nuclear import
pathway.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
During the last few years it became clear that human im-
munode¢ciency virus type 1 (HIV-1) di¡ers from other retro-
viruses in its ability to infect terminally di¡erentiated macro-
phages, namely non-dividing cells [1,2]. This function has been
attributed to the action of several karyophilic proteins which
are present in its preintegration complex (PIC). At least three
HIV-1 proteins are involved in nuclear import of the PIC,
thus displaying partially redundant nuclear localization activ-
ity: the HIV-1 matrix protein (MA), a nucleocapsid compo-
nent [3], the auxiliary protein viral protein r (Vpr) [4,5], and
the viral integrase [6]. The requirement for MA can be
observed only in viruses lacking Vpr and the converse is also
true; the Vpr nuclear import function is revealed only in the
background of MA mutants lacking the nuclear localization
signal (NLS) function [4,5,7]. In spite of these reports, the role
of MA in promoting nuclear import of the viral PIC is con-
troversial. Recently it has been demonstrated that its NLS is
‘weak’ [7^10] and it requires the co-participation of Vpr in
mediating nuclear import of the PIC. The viral endonuclease,
integrase, which is required for chromosomal insertion of the
viral genome, is also karyophilic and promotes productive
infection of growth arrested cells in the absence of the other
two PIC karyophilic proteins [6]. The signi¢cance of these
karyophilic proteins has been exquisitely illustrated by dem-
onstrating the absence of HIV infection due to the failure of
nuclear entry of the viral genome in NLS-mutants of this
virus [11]. The existence of redundant nuclear import activities
in HIV-1 suggests that its karyophilic proteins may use di¡er-
ent and distinct pathways. Indeed, these karyophilic proteins
possess NLSs of di¡erent sequences and charges. The HIV-1
MA possesses an NLS with features analogous to the proto-
typic NLS of the SV40 large T antigen [3,11]. On the other
hand, the NLS of Vpr is not yet fully characterized, and
the nuclear import activity of this protein was attributed
to either the negatively charged putative amphiphilic K-helix
[12] located between residues 17^34 [13,14] or to the arginine-
rich domain situated at the C-terminus of the protein [15].
The NLS of HIV-1 integrase has as yet not been determined
[6].
In the present work we have used peptides derived from
HIV-1 Vpr conjugated to labeled bovine serum albumin
(BSA) and the in-vitro nuclear import assay system, namely
permeabilized cultured cells, to better characterize the NLS
region of Vpr. Permeabilized cultured animal cells have been
extensively used as an in-vitro system to study various aspects
related to nuclear import of karyophilic proteins, as well as
the requirement of cellular proteins to promote such entry. In
such assay systems, £uorescently [16,17] or biotin [18] labeled
BSA molecules covalently conjugated to an NLS peptide are
usually used as a transport substrate. The choice of such a
protocol for labeling is not only due to the fact that most of
the NLS-bearing proteins are not available in their puri¢ed
form, but mainly because the labeling of such proteins may
lead to inactivation of their nuclear translocation ability.
Here, we have shown that peptides derived from the N-
terminal region putative helix of Vpr, and not from its C-
terminus ^ both of which were suggested to mediate nuclear
import of Vpr [13^15] ^ promoted entry of labeled BSA into
nuclei of permeabilized cells.
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2. Materials and methods
2.1. Cultured cells
Colo-205 (human colon adenocarcinoma cells (ATCC CCL 222))
were maintained in RPMI 1640 medium, supplemented with 10%
FCS, 0.3 g/l L-glutamine, 100 U/ml penicillin and 100 U/ml strepto-
mycin (Beit Haemek, Israel).
Monolayer cultures of HeLa cells were grown in DMEM growth
medium supplemented with 10% FCS as previously described [17].
2.2. Synthesis of linear peptides
Linear NLS peptides were synthesized on Rink amide resin (loading
0.5 mmol/g) using the Applied Biosystems Peptide Synthesizer model
433A, by the FastMoc chemistry. The peptides were cleaved from the
resin using tri£uoroacetic acid (TFA) with 5% anisole as a scavenger,
precipitated from cold ether, dissolved in 30% acetic acid and lyophi-
lized. Crude peptides were analyzed by reverse-phase HPLC (C3 col-
umn, gradient of 5^60% acetonitrile/triple distilled water (TDW) con-
taining 0.1% TFA, 35 min) and characterized by time of £ight-mass
spectrometry (TOF-MS) and amino acid analysis. The following pep-
tides were synthesized: SV40 large T-antigen NLS (PKKKRKVC),
SV40-NLS mutant (CGPKNKRKV), SV40-NLS reverse peptide
(CVKRKKKPG), VprN (C16NEWTLELLEELKNEAVRHF34),
VprN mutant (16NEATLELLPELKNPAVRHF34), VprC (C77RHS-
RIGVTRQRRARNGASRS96), HIV-MA-NLS (C25GKKKYK-
LKH33) and HIV-Nef-NLS (C7KRSMGGWSAIRERMRR22). Cys-
teine residues were added to the N-terminus or to the C-terminus of
the original sequences to promote binding to BSA.
2.3. Estimation of nuclear import by £uorescence microscopy
observations
HeLa cells were cultivated on 10-mm coverslips to a subcon£uent
density and then permeabilized with digitonin as described before [19]
and slightly modi¢ed recently [17]. Peptides bearing the NLS of the
SV40 large T-antigen, VprN, HIV-MA-NLS and VprC were cova-
lently attached to rhodamine labeled BSA molecules essentially as
described before [16] and translocation of the resulting £uorescently
labeled NLS-BSA molecules (FL-NLS-BSA) into nuclei of digitonin-
permeabilized HeLa cells was followed by £uorescent microscopy ob-
servations, as previously described [19].
2.4. Quantitative analysis of nuclear import in an in-vitro system
Nuclear import was quantitatively determined by the ELISA based
method using biotin-labeled BSA as described before [18] and recently
modi¢ed [20]. The results given are an average of triplicate ELISA
determination, standard deviation of which never exceeded þ 20%.
3. Results
3.1. The N-terminal helical region of Vpr, and not the
C-terminal region, mediates nuclear uptake
Peptides derived from the N- and C-terminal regions of Vpr
(designated VprN and VprC, see Table 1) were conjugated to
rhodamine-BSA and their karyophilic properties were tested
by £uorescent microscopy. As can be seen (Fig. 1), the VprN-
BSA conjugates accumulated within the cell nuclei. In con-
trast, in an ATP-depleted system, at 4‡C, as well as in the
presence of wheat germ agglutinin (WGA) and of N-ethyl
maleimide (NEM), VprN-BSA was retained in the cytoplasm,
completely excluded from the nuclei (Fig. 1 and data not
shown). The £uorescent microscopy observations were con-
¢rmed by a quantitative estimation of nuclear import using
the ELISA-based method. As can be seen (Table 1), in ATP-
depleted cells and at 4‡C, nuclear import was reduced by
about 75%, and in the presence of WGA and NEM by about
50% compared to the values obtained in the control system. In
this regard, the observed VprN mediated nuclear import re-
sembles in its features nuclear entry of SV40-NLS-BSA con-
jugates, which is considered to be the prototypic nuclear
transport substrate (Table 1 and [16]). The requirement for
ATP and the inhibition by WGA clearly suggest that the
VprN-BSA conjugates are translocated via the nuclear pore
complex (NPC) by a mechanism similar to that used by other
karyophilic proteins. On the other hand, VprN-BSA entry
into nuclei did not require the addition of soluble cytosolic
extract, as was established by £uorescent microscopy studies
(not shown) and by the ELISA based method (Table 1). Ad-
dition of cytosolic factors, which are lost during the perme-
abilization process, is essential for the reconstitution of the
nuclear import machinery in digitonin-permeabilized cells as
exempli¢ed by using the SV40 mediated nuclear import (Table
1 and [16]). The ability of VprN to promote nuclear import of
VprN-BSA in the absence of soluble factors may indicate that
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Table 1
The ability of VprN, but not of VprC, to mediate nuclear import of BSA conjugates in permeabilized cellsa
Conjugate: VprN-BSA VprC-BSA SV40-NLS-BSA
Experimental conditions Nuclear entry (%)b
With cytosolic factors 100 0 100
Without cytosolic factors 100 0 15.2
4‡C 25 N.D. 17
(3)ATP 26.7 N.D. 21.8
+WGA 53.6 N.D. 11.9
+NEM 46.7 N.D. 1.5
aPeptides bearing the sequences of residues 17^34 of HIV-1 Vpr protein (VprN), the C-terminal arginine rich domain of Vpr (residues 77^96,
VprC), and the NLS of SV40 large T-antigen were synthesized and conjugated biotinylated BSA. The entry of the conjugates into nuclei of
permeabilized Colo cells was estimated as described in Section 2. ATP was depleted as described [17]. WGA (0.6 mg/ml) and NEM (5 mM) were
preincubated for 30 min at room temperature with the permeabilized cells before adding the BSA conjugates.
bEntry of each conjugate in the presence of cytosolic factors was considered as 100%.
Table 2
In£uence of di¡erent peptides on nuclear import of £uorescently la-
beled VprN-BSA conjugatesa
Peptide Nuclear import of
Conjugate: VprN-BSA SV40-NLS-BSA
VprN + +
VprN mutant + 3
VprC 3 3
SV40-NLS +/3 3
SV40-NLS mutant + +
SV40-NLS reverse + +
HIV-MA-NLS 3 3
HIV-Nef-NLS 3 3
aSynthetic peptide bearing the sequence of residues 17^34 of HIV-1
Vpr protein (VprN) was conjugated to rhodamine-BSA and the nu-
clear import of the conjugates was followed by £uorescent micros-
copy. For peptide sequences and estimation of nuclear import see
Section 2. Peptides were added in a molar ratio (peptide/transport
substrate) of 140:1.
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Vpr uses a unique nuclear import pathway, as suggested be-
fore [5].
As opposed to the promotion of nuclear import activity by
VprN, VprC did not show any karyophilic properties, and its
conjugates with BSA were retained in the cytoplasm of the
permeabilized cells (Table 1). However, VprC as well as pep-
tides bearing the NLS sequences of the HIV proteins Nef and
MA, strongly inhibited nuclear import of VprN-BSA (Table
2).
Since nuclear entry of VprN-BSA resembles in its features
nuclear entry of other karyophilic proteins, it was anticipated
that the free VprN peptide will e⁄ciently block the entry of
VprN-BSA. Inhibition of nuclear import of NLS-BSA conju-
gates by free NLS peptides has been shown before [16,20], and
is used to demonstrate speci¢c nuclear import of karyophilic
proteins. Surprisingly, no inhibition was observed when the
free VprN peptide was added to the nuclear import assay
system. Fluorescent microscopy studies revealed that the £uo-
rescent VprN-BSA molecules accumulated in the nuclei in the
presence of VprN peptide (as well as in its absence) (Table 2).
Also, the addition of the SV40-NLS peptide hardly inhibited
nuclear entry of VprN-BSA, while it completely blocked nu-
clear entry of SV40-NLS-BSA (Table 2). No inhibition was
observed either in the presence of the mutant SV40-NLS, the
peptide bearing the reverse sequence of the SV40-NLS, and
the mutant VprN (VprN W18A, E24P, E29P) (Table 2). It is
noteworthy that recently it has been reported that SV40-NLS
peptide did not inhibit the binding of Vpr to karyopherin-K
[7].
3.2. The e¡ect of free VprN peptide on nuclear import in
permeabilized cells: promotion of non-speci¢c
translocation
As mentioned above (and see Table 2), the free VprN pep-
tide did not inhibit nuclear entry either of VprN-BSA or of
SV40-BSA conjugate. It was therefore of interest to investi-
gate its e¡ect on the entry of other NLS-BSA conjugates.
Surprisingly, in the presence of VprN peptide, transport sub-
strates such as SV40-NLS-BSA were found to accumulate
within nuclei even in ATP depleted cells and/or in the absence
of cytosolic factors, conditions in which, otherwise, such con-
jugates are exclusively retained in the cytoplasm (see also Ta-
ble 1). A non-speci¢c accumulation of SV40-NLS-BSA within
the intranuclear space is, thus, observed in the presence of
VprN peptide. This, indeed, was con¢rmed by the results
(Fig. 2) showing that £uorescent BSA molecules lacking any
conjugated NLS peptides, which by all means are not karyo-
philic and therefore should be retained in the cytoplasm, were
found within the nuclei in the presence of VprN peptide.
Furthermore, the addition of VprN peptide caused signi¢cant
nuclear accumulation of HIV-MA-NLS-BSA conjugates (Fig.
2), nuclear entry of which is usually poor and almost unde-
tected ([10] and unpublished results). Careful examination of
the nuclei containing the £uorescently labeled molecules,
which accumulated in the presence of VprN (Fig. 2a,c,d),
shows that they retained their shape and that their nuclear
envelope appears intact. Total disruption of the nuclear enve-
lope by the VprN peptide seems unlikely, since it should result
in an equal distribution of the dye within the whole micro-
scopic ¢eld (as in the case following the addition of a deter-
gent, such as Triton X-100), but not in accumulation of the
£uorescent dye within the intranuclear space.
4. Discussion
The results of the present work clearly attribute the karyo-
philic properties of the HIV-1 Vpr to its putative K-helical
region located between residues 17^34. This conclusion is
FEBS 20409 18-6-98
Fig. 1. Fluorescent microscopy observations of VprN-mediated nuclear uptake. The experimental conditions were as described in Section 2. Nu-
clear uptake of rhodamine-VprN-BSA was determined in the following systems. a: In the absence of cytosolic factors; b: at 4‡C; c: with VprC
(molar ratio of 200:1 to the transport substrate); d: with WGA (0.6 mg/ml).
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based mainly on our observation showing that VprN was able
to mediate nuclear entry of £uorescently labeled BSA.
Although translocation of VprN-BSA conjugates into nuclei
of permeabilized cells did not require the addition of cytosolic
factors, it was ATP and temperature dependent and was in-
hibited by WGA and NEM, properties which characterize
typical NLS-mediated nuclear import of karyophilic proteins.
On the other hand, a peptide derived from the arginine-rich
domain located between residues 77^96 at the C-terminus of
Vpr (VprC), failed to show karyophilic properties when con-
jugated to BSA. VprC-BSA conjugates were retained in the
cytoplasm of the permeabilized cells. Our present work
strengthens previous suggestions, based on genetic studies us-
ing Vpr mutants [13,14], that the N-terminal putative K-helical
region of Vpr confers the karyophilic properties of this pro-
tein. The present use of VprN-BSA conjugates enables us to
limit the active region to residues 17^34 and to prove for the
¢rst time that this region, and not VprC, possesses an NLS
activity. This region is negatively charged, as opposed to the
positively charged consensus NLS sequences, such as that of
SV40 T-antigen [21].
The unique properties of the Vpr-NLS region indicate that
the Vpr protein uses a speci¢c, yet uncharacterized, receptor,
di¡erent from that used by the positively charged NLSs such
as K-importin [22^24]. Indeed, this was suggested before [5],
and may explain our results showing nuclear entry of VprN-
BSA in the absence of cytosolic factors. Evidently, VprN (as
well as Vpr) may interact with cellullar or nuclear envelope
components which are retained within the permeabilized cells
following the digitonin treatment. The result showing that
SV40-NLS peptide hardly inhibited nuclear import of the
VprN-BSA, as opposed to its ability to block nuclear import
of SV40-NLS-BSA conjugates, strengthens our above assump-
tion and ¢ts previous studies showing that induction of nu-
clear entry of HIV-PIC by Vpr was not inhibited by SV40-
NLS peptide [5].
Inhibition of nuclear entry of VprN-BSA conjugate by
VprC, Nef-NLS and HIV-MA-NLS peptides may be ex-
plained by electrostatic interaction between these positively
charged peptides and the negatively charged VprN. Since
VprN and VprC are located within the same protein, an intra-
molecular interaction between these two regions can be pro-
posed, suggesting a regulatory role for VprC. This will be
clari¢ed following future determination of the three-dimen-
sional structure of Vpr.
Interestingly, addition of free VprN to the in-vitro nuclear
import assay system promoted nuclear entry of £uorescently
labeled conjugates which otherwise would have been retained
in the cytoplasm. Nuclear presence of SV40-NLS-BSA conju-
gates in ATP depleted cells following the addition of free
VprN peptide could have been explained by an electrostatic
interaction between the positively charged NLS and the neg-
atively charged DNA in the nuclei. The same sequence of
events could have explained similar results obtained with
HIV-MA-NLS-BSA conjugates, which under regular condi-
tions and even in the presence of ATP and cytosolic factors
remain in the cytoplasm (data not shown and see also [10]).
However, the promotion of nuclear uptake of BSA molecules
lacking any positively charged NLS, following free VprN pep-
tide addition, cannot be explained by an electrostatic interac-
tion with the DNA. Therefore, it is our view that the free
VprN peptides do not act like a detergent and do not totally
disrupt or solubilize the nuclear envelope. This view is sup-
ported by our microscopic observations showing preservation
of the nuclear shape in the presence of VprN. In this regard, it
should be mentioned that recently it has been shown that Vpr
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Fig. 2. E¡ect of free VprN on nuclear import. VprN peptide was added in a molar ratio of 200:1 to the following systems. a: Rhodamine-
SV40-BSA without cytosolic factors and in the absence of ATP. b: The same as a but in the absence of VprN. c: MA-NLS-rhodamine-BSA.
d: Rhodamine-BSA (without NLS).
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induces the nuclear entry of the high molecular weight HIV-
PIC [7] and therefore a regulatory e¡ect on nuclear entry was
attributed to Vpr. Our results indicate the same e¡ect and
pinpoint the regulatory activity to the NLS region of Vpr.
VprN may either interact with karyophilic or non-karyophilic
proteins and allow their entry into the nuclei, or alternatively
interact with the NPC and increase its permeability or its pore
size. Currently, studies in our laboratory are conducted to
clarify these possibilities and to ¢nd out whether VprN inter-
acts directly with the NPC.
During the preparation of the present manuscript, a paper
has been published [25] showing unequivocally, by molecular
biology methods, that only the nuclear transport activity of
the HIV-1 Vpr, and not its other biological functions, is lo-
cated within the putative amphipathic helical structure. These
results strongly con¢rm the results of the present work.
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